This seems much more related to the specific political economy of government health institutions and their interaction with electoral systems, than a specific causal attribution to systems based on capital. That is to say, there are many failure and success modes of a government response to drugs that are orthogonal, or at least only loosely correlated, with the specific marker system that is implemented.